High Tower Advisors, LLC Astrazeneca PLC Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, High Tower Advisors, LLC holds 726,665 shares of AZN stock, worth $48.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

726,665

Previous 734,019 1.0%

Holding current value

$48.2 Million

Previous $57.2 Million 1.09%

% of portfolio

0.08%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $563,831 - $644,357	-7,354 Reduced 1.0%	726,665 $56.6 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $2.25 Million - $2.72 Million	33,633 Added 4.8%	734,019 $57.2 Million
Q1 2024 May 06, 2024	BUY	$61.03 - $69.57 $1.65 Million - $1.89 Million	27,103 Added 4.03%	700,386 $47.5 Million
Q4 2023 Feb 12, 2024	BUY	$61.89 - $69.28 $1.2 Million - $1.35 Million	19,440 Added 2.97%	673,283 $45.3 Million
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $24.6 Million - $27.1 Million	378,601 Added 137.55%	653,843 $44.3 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $3.41 Million - $3.7 Million	48,818 Added 21.56%	275,242 $19.7 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $1.23 Million - $1.39 Million	19,422 Added 9.38%	226,424 $15.7 Million
Q4 2022 Feb 08, 2023	SELL	$54.21 - $70.44 $481,493 - $625,648	-8,882 Reduced 4.11%	207,002 $14 Million
Q3 2022 Nov 09, 2022	BUY	$53.02 - $135.75 $1.41 Million - $3.61 Million	26,600 Added 14.05%	215,884 $11.9 Million
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $2.96 Million - $3.55 Million	49,926 Added 35.83%	189,284 $12.5 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $3.53 Million - $4.25 Million	-63,390 Reduced 31.27%	139,358 $9.25 Million
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $328,549 - $388,214	6,082 Added 3.09%	202,748 $11.8 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $2.05 Million - $2.24 Million	36,846 Added 23.05%	196,666 $11.8 Million
Q2 2021 Aug 06, 2021	BUY	$48.42 - $60.18 $1.82 Million - $2.27 Million	37,641 Added 30.81%	159,820 $9.58 Million
Q1 2021 May 10, 2021	BUY	$47.16 - $54.44 $859,113 - $991,733	18,217 Added 17.52%	122,179 $6.01 Million
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $1.27 Million - $1.52 Million	26,131 Added 33.57%	103,962 $5.15 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $1.42 Million - $1.63 Million	26,733 Added 52.32%	77,831 $4.26 Million
Q2 2020 Aug 10, 2020	SELL	$43.1 - $55.31 $57,797 - $74,170	-1,341 Reduced 2.56%	51,098 $2.7 Million
Q1 2020 May 21, 2020	BUY	$37.79 - $51.33 $1.98 Million - $2.69 Million	52,439 New	52,439 $2.34 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $2.41 Million - $2.86 Million	-56,678 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $296,968 - $336,568	7,402 Added 15.02%	56,678 $2.52 Million
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $133,238 - $148,964	-3,574 Reduced 6.76%	49,276 $2.03 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $168,612 - $204,388	-4,751 Reduced 8.25%	52,850 $2.13 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $54,995 - $61,903	-1,492 Reduced 2.52%	57,601 $2.19 Million
Q3 2018 Nov 09, 2018	SELL	$34.76 - $39.72 $2.04 Million - $2.33 Million	-58,671 Reduced 49.82%	59,093 $2.35 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $214,624 - $230,154	-6,212 Reduced 5.01%	117,764 $4.14 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $261,847 - $290,915	-7,942 Reduced 6.02%	123,976 $4.33 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $463,251 - $502,084	-14,436 Reduced 9.86%	131,918 $4.57 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $287,485 - $337,518	9,927 Added 7.28%	146,354 $4.96 Million
Q2 2017 Aug 14, 2017	BUY	N/A	136,427	136,427 $4.64 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Astrazeneca PLC Transaction History